Osiris strikes deal with Stryker for bone-repair product
Osiris Therapeutics strikes an exclusive marketing deal with Stryker for its Bio4 bone-allograft product. Osiris Therapeutics said it struck an exclusive marketing deal with Stryker (NYSE:SYK) for its Bio4 bone allograft. Osiris Therapeutics Inc., Stryker Corp.News Well, Orthopedics, Regenerative Medicineread more (Source: Mass Device)
Source: Mass Device - January 5, 2015 Category: Medical Equipment Authors: Val Kennedy Source Type: news

Plasma Marker Predicts Allograft Failure in Lung Transplant
Average donor - derived cell - free DNA in highest tertile linked to increased risk for allograft failure (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Pathology, Pulmonology, Surgery, Journal, Source Type: news

Zimmer Announces FDA Clearance of the Stand-alone Optio-C(R) Anterior Cervical System for use with Structural Allograft/Autograft
The Optio-C System is a next-generation, modular stand-alone cervical device that offers allograft/autograft and PEEK options and delivers the strength, stability and fusion potential of a traditional ACDF MINNEAPOLIS, Nov. 10, 2014 -- (Healthcare Sales... Devices, Orthopaedic, Neurosurgery, FDAZimmer Spine, Optio-C, Anterior Cervical Plate, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2014 Category: Pharmaceuticals Source Type: news

Worse Kidney Allograft Survival for African American ChildrenWorse Kidney Allograft Survival for African American Children
Kidney allograft survival is worse for African American children than for white or Hispanic children, according to new research. Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 4, 2014 Category: Transplant Surgery Tags: Nephrology News Source Type: news

COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A
Here's a look at some of the top regulatory stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies Covidien plans to sell some vascular therapies ahead of Medtronic merger October 24, 2014 by Brad Perriello Wright Medical Group Inc., Covidien, Food & Drug Administration (FDA), Globus Medic...
Source: Mass Device - October 29, 2014 Category: Medical Equipment Authors: MassDevice Source Type: news

Aftermath of merger and FDA decision could be huge for Wright Medical
After committing to grow its extremities business through its sale of its OrthoRecon business in 2013, Wright Medical Group's merger with Tornier and the U.S. Food & Drug Administration's approvable letter for its Augment Bone Graft product, the company is moving full speed ahead. Wright Medical announced the merger and the progress with Augment yesterday, but during a conference call yesterday afternoon, Bob Palmisano, Wright Medical's CEO, tried to temper expectations when it comes to the company's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2014 Category: Pharmaceuticals Authors: Michael Sheffield Source Type: news

Wright Medical to acquire Tornier for $3.3B in inversion deal
Wright Medical says it plans to acquire Tornier for $3.3 billion and announces an approvable letter from the FDA for its Augment bone graft. Wright Medical Group Inc., Food & Drug Administration (FDA), Tornier Inc.News Well, Mergers & Acquisitions, Orthopedics, Regulatory/Compliance, Resorbable bone materialsread more (Source: Mass Device)
Source: Mass Device - October 27, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Globus Medical snaps up allograft maker Transplant Technologies
Globus Medical acquires Transplant Technologies of Texas, a provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount. Globus Medical, Transplant Technologies of TexasNews Well, Mergers & Acquisitions, Orthopedicsread more (Source: Mass Device)
Source: Mass Device - October 27, 2014 Category: Medical Equipment Authors: Alexander Soule Source Type: news

Which membranes can be exposed in bone graft sites?
When covering bone graft sites in fresh extraction sockets or ridge augmentation can the membranes be exposed? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - October 27, 2014 Category: Dentistry Authors: osseonews Tags: Dental Implants Q&A Source Type: news

Globus Medical buys San Antonio biomedical firm
Transplant Technologies of Texas Ltd. has a new owner. The San Antonio company that supplies human tissue products for the spine, orthopedics, sports medicine, dental and wound-care markets has been bought by Globus Medical Inc. Audubon, Penn.-based Globus Medical (NYSE: GMED) manufactures musculoskeletal implants. Transplant Technologies supplies bone allografts, biomaterials and soft tissue products. Globus Chairman and CEO David Paul said in a news release that management sees the acquisition… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 25, 2014 Category: Biotechnology Authors: James Aldridge Source Type: news

Globus Medical buys San Antonio biomedical firm
Transplant Technologies of Texas Ltd. has a new owner. The San Antonio company that supplies human tissue products for the spine, orthopedics, sports medicine, dental and wound-care markets has been bought by Globus Medical Inc. Audubon, Penn.-based Globus Medical (NYSE: GMED) manufactures musculoskeletal implants. Transplant Technologies supplies bone allografts, biomaterials and soft tissue products. Globus Chairman and CEO David Paul said in a news release that management sees the acquisition… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 25, 2014 Category: Pharmaceuticals Authors: James Aldridge Source Type: news

Adverse Events, LOS, Readmission After ICBG in Spinal FusionAdverse Events, LOS, Readmission After ICBG in Spinal Fusion
How does the use of iliac crest bone graft in spinal fusion affect postoperative adverse events, hospital length of stay, and readmission rates? Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2014 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

FDA panel recommends PMA process for CryoLife heart valve
An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol. CryoLife, Food & Drug Administration (FDA)News Well, 510(k), Pre-Market Approval (PMA), Regulatory/Compliance, Replacement Heart Valvesread more (Source: Mass Device)
Source: Mass Device - October 10, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

High-Tech Heart Valves Deserve Full PMA Review: FDA AdvisorsHigh-Tech Heart Valves Deserve Full PMA Review: FDA Advisors
There was no official vote, nor was one called for. The panel mulled whether "more-than-minimally-manipulated" allograft valves in general needed more than "substantial equivalence" for approval. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 10, 2014 Category: Cardiology Tags: Cardiology News Source Type: news

Bone graft infection: any recommendations?
I did an extraction and had to do a bone graft with a titanium membrane. Patient returned with persistent soreness and bad taste. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - September 22, 2014 Category: Dentistry Authors: osseonews Tags: Dental Implants Q&A Source Type: news

Zimmer signs allograft distro agreement with MiMedx
MiMedx licenses its dHACM allografts to orthopedics giant Zimmer non-exclusively on a private label basis. Zimmer Holdings, MiMedx Group Inc.News Well, Deals Roundup, Orthopedics, Regenerative Medicineread more (Source: Mass Device)
Source: Mass Device - September 18, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Can carbon monoxide-poisoned victims be organ donors? - Fujisaki N, Nakao A, Osako T, Nishimura T, Yamada T, Kohama K, Sakata H, Ishikawa-Aoyama M, Kotani J.
The increasing demand for organ allografts to treat end-stage organ failure has driven changes in traditional donor criteria. Patients who have succumbed to carbon monoxide (CO) poisoning, a common cause of toxicological mortality, are usually rejected as ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 14, 2014 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Stem cells in the skeletal muscle promote the regeneration of severe nerve peripheral injury
(Neural Regeneration Research) Skeletal muscle derived-multipotent stem cells were transplanted for the peripheral nerve injury, having the irreversible long nerve gap, using acellular conduit bridging. Applied cells differentiated into all of axon support cells, and contributed to increased vascular formation, which is favorable for blood supply and waste product excretion, providing the sustained expression of neurotrophic and nerve/vascular growth factors. Then, over 94 percent of axonal regeneration was achieved during eight weeks, and this was more effective (about triple) than healthy nerve autograft. (Source: EurekA...
Source: EurekAlert! - Medicine and Health - August 13, 2014 Category: Global & Universal Source Type: news

A rhesus monkey model of radial nerve injury for evaluating peripheral nerve repair
(Neural Regeneration Research) Current research on bone marrow stem cell transplantation and autologous or xenogenic nerve transplantation for peripheral nerve regeneration has mainly focused on the repair of peripheral nerve defects in rodents. Dr. Dong Wang and his team, First Affiliated Hospital of Sun Yat-sen University, China established a standardized experimental model of 2.5 cm-long radial nerve defects in rhesus monkeys and evaluated the effect of repair on peripheral nerve injury. The quality of nerve regeneration in the bone marrow stem cells-laden allografts was comparable to that achieved with autografts. (Sou...
Source: EurekAlert! - Medicine and Health - July 17, 2014 Category: Global & Universal Source Type: news

AOSSM: Concussion Genes and ACL Autografts
(MedPage Today) -- Studies presented at the American Orthopaedic Society for Sports Medicine meeting revealed a possible genetic connection between concussions and recovery time, and differences in reconstructed anterior cruciate ligaments failure rates based on grafting tissue type. (Source: MedPage Today Emergency Medicine)
Source: MedPage Today Emergency Medicine - July 13, 2014 Category: Emergency Medicine Source Type: news

ACL reconstructions may last longer with autografts
Anterior Cruciate Ligament (ACL) reconstructions occur more than 200,000 times a year, but the type of material used to create a new ligament may determine how long you stay in the game, say researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 11, 2014 Category: Science Source Type: news

ACL reconstructions may last longer with autografts
(American Orthopaedic Society for Sports Medicine) Anterior cruciate ligament reconstructions occur more than 200,000 times a year, but the type of material used to create a new ligament may determine how long you stay in the game, say researchers presenting their work today at the Annual Meeting of the American Orthopaedic Society of Sports Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2014 Category: Global & Universal Source Type: news

Do Allografts Equal Organs?
(MedPage Today) -- On July 3, the definition of an organ for procurement and transplantation changed to include vascularized composite allografts (VCAs) -- faces, arms, legs, hands, larynxes, and abdominal walls. What are our obligations to potential organ donors? (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - July 11, 2014 Category: Surgery Source Type: news

Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-analysis of Prospective TrialsCoronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-analysis of Prospective Trials
Which method should you use for detecting cardiac allograft vasculopathy? Learn about pros and cons of each. Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2014 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Pomahac Awarded Department of Defense Funding for Nerve Repair Research
Bohdan Pomahac, MD, director of Plastic Surgery Transplantation, recently received a grant to develop branched allografts for complex nerve repair in collaboration with AxoGen, Inc. (Source: BWH News)
Source: BWH News - June 18, 2014 Category: Hospital Management Source Type: news

Can I still graft integrated implants?
Assuming the implants are integrated and the soft tissue is intact over the implants, can I bone graft over the facials of these implants after all this time? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 16, 2014 Category: Dentistry Authors: osseonews Tags: Dental Implant Cases Source Type: news

From beer to bone implants: New uses for spent brewery grain | MassDevice.com On Call
The waste from breweries may have surprising applications in bone implants, grafts and other orthopedic devices. MASSDEVICE ON CALL — A team of researchers is working out a new way to turn the brewery waste into orthopedic devices, leveraging substances naturally found in spent grain for bone grafts and implants, Medgadget reports. News Well, On Call, Innovation, Orthopedicsread more (Source: Mass Device)
Source: Mass Device - June 11, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Beer brewing waste could help bone regeneration
Biomaterials for bone regeneration have been developed by researchers from beer brewing waste. The waste obtained from the beer brewing process contains the main chemical components found in bones (phosphorus, calcium, magnesium and silica), that after undergoing modification processes, this waste can be used as support or scaffold to promote bone regeneration for medical applications such as coating prosthesis or bone grafts, researchers report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2014 Category: Science Source Type: news

Stryker suit alleges that DePuy helped sales reps defect from company | Medtech legal news for the week of June 9, 2014
Here's a look at some of the top legal news stories for medical device companies this week: Stryker accuses DePuy of raiding California sales team; Humana levels racketeering lawsuit against Medtronic over Infuse bone graft; Ex-ArthroCare execs convicted in $400M fraud case; Medtronic: Solicitor General got it wrong on preemption; Spinal Kinetics reels in $34M, settles patent spat with DePuy Synthes. Stryker accuses DePuy of raiding California sales team June 3, 2014 by Brad Perriello ArthroCare Corp., Dept. of Justice (DOJ), DePuy Synthes, Humana, Johnson & Johnson, Medtronic, Spinal Kinetics, Stryker Cor...
Source: Mass Device - June 9, 2014 Category: Medical Equipment Authors: MassDevice Source Type: news

Insurance Company Files Racketeering Claim Against Medtronic
Insurance company Humana recently filed racketeering charges against Medtronic for allegedly giving payouts to surgeons to promote off-label use of the company’s bone growth product in medical journals. The insurer said that it unnecessarily paid for Infuse bone-graft treatments when less expensive therapies should have been used, based on established medical guidelines. (Source: Medical Design Online News)
Source: Medical Design Online News - June 6, 2014 Category: Medical Equipment Source Type: news

Medtronic: Solicitor General got it wrong on preemption
Medtronic says Solicitor General Donald Verrilli's interpretation of federal preemption law is mistaken. Medtronic (NYSE:MDT) last week told an appeals court that U.S. solicitor general Donald Verrilli got it wrong when he interpreted federal preemption rules in medical device product liability cases, as it fights the appeal of a preempted lawsuit filed over its Infuse bone graft product. MedtronicLegal News, News Well, Preemptionread more (Source: Mass Device)
Source: Mass Device - June 3, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Humana levels racketeering lawsuit against Medtronic over Infuse bone graft
Health insurer Humana levels a Racketeer Influenced & Corrupt Organizations lawsuit against Medtronic over its Infuse bone graft product. UPDATED June 2, 2014, with comment from Medtronic. Humana, MedtronicLegal News, News Well, Clinical Trials, Resorbable bone materialsread more (Source: Mass Device)
Source: Mass Device - June 2, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Diabetic Ulcers Heal Faster if Skin Substitute Applied WeeklyDiabetic Ulcers Heal Faster if Skin Substitute Applied Weekly
Nearly twice as many diabetic foot ulcers totally healed with weekly dehydrated amniotic-membrane allografts as with 2 biweekly applications, researchers report. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 12, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Medtronic Agrees To Settle Certain INFUSE Bone Graft Product Liability Cases
Medtronic, Inc. recently announced that it has agreed with certain plaintiffs' counsel to settle their inventories of filed and unfiled product liability claims related to INFUSE Bone Graft. Under the terms of the agreement, Medtronic has agreed, subject to certain conditions, to resolve the claims of an estimated 950 claimants for a total payment of approximately $22M. (Source: Medical Design Online News)
Source: Medical Design Online News - May 7, 2014 Category: Medical Equipment Source Type: news

Medtronic inks $22M deal to settle 950 Infuse lawsuits
Medtronic says it agreed to settle about 950 product liability lawsuits filed over its controversial Infuse bone graft product for $22 million, but admits no wrongdoing. Medtronic (NYSE:MDT) said today that it agreed to pay $22 million to settle an estimated 950 lawsuits filed over its controversial Infuse bone graft product, admitting to no wrongdoing in what it termed a "compromise" of disputed claims. MedtronicLegal News, News Well, Resorbable bone materials, Spinalread more (Source: Mass Device)
Source: Mass Device - May 6, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

GE gets behind Cerapedics and its i-FACTOR bone graft
Colorado-based Cerapedics closes $9 million in venture debt financing from GE Capital's Health Financial Services in support of the i-FACTOR Peptide Enhanced Bone Graft. Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company. Cerapedics Inc., GE HealthcareNews Well, Funding Roundup, Orthobiologics, Resorbable bone materialsread more (Source: Mass Device)
Source: Mass Device - April 21, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Functional outcomes and return to sports after acute repair, chronic repair, and allograft reconstruction for proximal hamstring ruptures - Rust DA, Giveans MR, Stone RM, Samuelson KM, Larson CM.
BACKGROUND:There are limited data regarding outcomes and return to sports after surgery for acute versus chronic proximal hamstring ruptures. HYPOTHESIS:Surgery for chronic proximal hamstring ruptures leads to improved outcomes and return to sports but at ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 12, 2014 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Are These Medical Devices Too Dangerous? (Medtronic INFUSE Bone Graft/LT-CAGE)
(Source: MDDI)
Source: MDDI - April 9, 2014 Category: Medical Equipment Authors: Jamie Hartford Tags: Regulatory and Compliance Source Type: news

CDRH, Wright Medical Come to Terms in Dispute Over Augment Bone Graft
(Source: MDDI)
Source: MDDI - April 2, 2014 Category: Medical Equipment Authors: Jamie Hartford Tags: Regulatory and Compliance Source Type: news

Positive results for meniscal allograft transplantation surgery for young athletes with knee pain
Patients undergoing meniscal allograft transplantation (MAT) surgery require an additional operation approximately 32% of the time, but overall see a 95% success rate after an average five-year follow-up, according to new research released at the American Orthopaedic Society for Sports Medicine's (AOSSM) Specialty Day."Our research shows a positive mid to long-term outcome for patients who require MAT surgery," commented lead author Dr. Frank McCormick from Holy Cross Orthopedic Institute in Fort Lauderdale Florida, and Rush University Medical Center in Chicago. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 18, 2014 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

Young athletes with knee pain may turn to meniscus transplant
Patients undergoing meniscal allograft transplantation (MAT) surgery require an additional operation approximately 32% of the time, but overall see a 95% success rate after an average five-year follow-up, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 15, 2014 Category: Science Source Type: news

Young athletes with knee pain may turn to meniscus transplant
(American Orthopaedic Society for Sports Medicine) Patients undergoing meniscal allograft transplantation surgery require an additional operation approximately 32 percent of the time, but overall see a 95 percent success rate after an average five-year follow-up, according to new research released today at the American Orthopaedic Society for Sports Medicine's Specialty Day. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2014 Category: Global & Universal Source Type: news

Ahmed’s journey of 3,000 miles ends with a single step
If you met Ahmed al-Fardan today, walking with the aid of crutches, you might mistake him for a student athlete recovering from an injury. The talkative 16-year-old recently started college courses at Middlesex Community College, where he’s thinking of starting a pre-med program. And when he’s not in class, his mother Ameera often finds him reading or writing short stories. She says it’s already getting hard to believe that only two years ago, her son was all but confined to a wheelchair. That’s because Ahmed is a lifelong member of one of the world’s most exclusive clubs—he is one of as...
Source: Thrive, Children's Hospital Boston - March 14, 2014 Category: Pediatrics Authors: Kipaya Kapiga Tags: All posts Source Type: news

Wright Medical can submit more data to FDA for Augment bone graft
Wright Medical says it struck a deal with the FDA to submit more data on its Augment bone graft, previously deemed unapprovable by the watchdog agency. Wright Medical (NSDQ:WMGI) said the FDA agreed to let it submit additional data for its pre-market approval application for the Augment bone graft it bought along with BioMimetic Therapeutics in 2012. Wright Medical Group Inc., Food & Drug Administration (FDA)News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Resorbable bone materialsread more (Source: Mass Device)
Source: Mass Device - March 11, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Delayed bone grafting of an extraction site: how to go about it?
My question is on a subsequent visit, I would like to bone graft this site in preparation for a dental implant, but I am not sure exactly how to go about it. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - March 10, 2014 Category: Dentistry Authors: osseonews Tags: Dental Implants Q&A Source Type: news

Medtronic Facing Lawsuits Over Bone Growth Product
Medtronic has confirmed that around 1,000 people have sued the company over complications arising from its controversial bone graft product, Infuse. (Source: Medical Design Online News)
Source: Medical Design Online News - March 10, 2014 Category: Medical Equipment Source Type: news

What Are Complications of Fractures?
Discussion Fifth metatarsal fractures are a common fracture of the foot and are the most common metatarsal fracture in children> 5 years of age and adults. There is a peak age distribution in the second and fifth decades of life. Teenage boys in organized sports are one of the most common groups affected. In acute fractures, acute pain and inability to walk are common presentations, whereas in a stress fracture an increase in activity, or chronic repetitive forces are at play. Fifth metatarsal fractures have various classifications. Fracture locations from proximal to distal include avulsion fractures (a common acute fr...
Source: PediatricEducation.org - March 10, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Demineralised Bone Matrix Allograft in Spinal FusionDemineralised Bone Matrix Allograft in Spinal Fusion
This article presents a histological analysis of demineralised bone matrix and its effectiveness in enhancing posterior fusion of the spine. BMC Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2014 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Pessimistic Wright Medical wins FDA date for Augment
Wright Medical says it's not optimistic about an FDA dispute resolution panel this May on its Augment biologic bone graft. Wright Medical (NSDQ:WMGI) said it's not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012. Wright Medical Group Inc., BioMimetic Therapeutics Inc.News Well, MassDevice.com Earnings Roundup, 2013, Orthobiologics, Orthopedics, Q4read more (Source: Mass Device)
Source: Mass Device - February 25, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news